Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • LEAD: A low-cost Covid testing method using pencil graphite

Importance of Organoid Technology in Cancer Research

Recent advents in the arena of diabetic kidney disease

LEAD: A low-cost Covid testing method using pencil graphite
  • BiotechToday
  • World

LEAD: A low-cost Covid testing method using pencil graphite

BioTech Today August 19, 2021August 19, 2021

Sayak Banerjee, Amity University Kolkata

COVID-19 has already taken over 4 million lives around the world, hence testing is essential for understanding the virus and controlling its spread. Currently, the tests are restricted by two factors, time taken and the accuracy required for analyzing a sample. The third factor which poses a challenge towards the present COVID-19 testing is cost. Most of the tests that have been developed to date are expensive to produce and necessitate trained workers for administering and analyzing the tests. This factor is the sole reason for which testing has become highly inaccessible in low and middle-income communities. Consequently, individuals remain at a greater risk of being susceptible to viral transmission.

To date, the tests are not sufficiently rapid, low-cost, or scalable to allow for broad COVID-19 testing. Researchers from The University of Pennsylvania have developed a novel electrochemical test using graphite electrodes. The lead researcher was César de la Fuente, Assistant Professor in Bioengineering and Microbiology. He had mentioned that this test takes only 6.5 minutes to produce 100% accurate results from oropharyngeal and nasopharyngeal samples. Moreover, these electrodes cut the cost to $1.50 per test, thus addressing time, expense, and accuracy.

The LEAD COVID-19 testing kit:

de la Fuente had focused on the invention of RAPID (Real-time Accurate Portable Impedimetric Detection) before this research. It is a COVID-19 testing kit that makes use of screen-printed electrodes. In his new research published in PNAS, he has presented LEAD (Low-cost Electrochemical Advanced Diagnostic) employing the same concept rather than without costly equipment. By altering just the building material of the electrodes, the cost has declined from $4.67 per test (RAPID) to $1.50 per test (LEAD).

The majority of the commercially available rapid tests is generally antigen-based and show low sensitivity. This drawback restricts its potential to precisely determine the asymptomatic individuals, thereby inhibiting the proper regulation of viral spread. LEAD, the COVID-19 testing kit that the researchers had reported about, utilizes highly accessible inexpensive materials. The robustness and accuracy of LEAD were assessed by analyzing 113 clinical samples especially the infectious SARS-CoV-2 UK variant.

 The lead researcher had confirmed that both RAPID and LEAD function on the same principle of electrochemistry. Nevertheless, LEAD is easier to assemble than RAPID because anyone can use it. Its high accessibility comes from the usage of the abundant material graphite that is even present in pencils. The functioning of LEAD is exhibited over a graph where when the sample is positive the COVID-19 spike protein binds to the electrode. This prevents the emission of a signal thus resulting in a small peak or else LEAD always produces a high peak.

 Significance of LEAD

 The Penn researchers are still working to enhance their tests’ stability and technology to produce an effective version of LEAD. More and more clinical studies are being performed to bring LEAD to be used as a COVID-19 testing kit shortly. de la Fuente regarded their test design to be multiplexing, enabling the detection of multiple bacteria and viruses in a sample. LEAD’s time and cost efficiency might make it the first electrochemical COVID-19 test in the future markets thriving indefinitely.

Also read: Modest eruptions may cascade into a catastrophic disaster

Reference:

  1. Lima, L. F. de, Ferreira, A. L., Torres, M. D. T., Araujo, W. R. de, & Fuente-Nunez, C. de la. (2021). Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes. Proceedings of the National Academy of Sciences, 118(30). https://doi.org/10.1073/pnas.2106724118
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Author info:

Sayak Banerjee is a 3rd year Biotechnology Engineering Student with great interest in Immunology and Molecular genetics. He is a creative scientific writer in Bioxone with an inclination towards gaining knowledge regarding vast sections of Biotechnology and emphasizing himself in various wet lab skills.

Publications:

  • https://bioxone.in/news/worldnews/car-t-cells-scientists-discover-on-off-switches-for-cell-immunotherapy/
  • https://bioxone.in/news/worldnews/neutrophil-derived-nanovesicles-a-novel-drug-delivery-system/
  • https://bioxone.in/news/worldnews/pig-to-human-heart-transplantation-a-solution-to-the-rarity-of-donor-organs/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged antigen bacteria bioengineering biosensor COVID-19 Diagnostic electrochemistry electrodes graphite Microbiology nasal oral saliva SARS-CoV-2 viral infection

3 thoughts on “LEAD: A low-cost Covid testing method using pencil graphite”

  1. Pingback: NMD-targeted isoforms discovered in human cells - BioXone
  2. Pingback: Fetal membranes can heal themselves - BioXone
  3. Pingback: Protection against Malaria parasite using a unique histone - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Recent advents in the arena of diabetic kidney disease

bioxone August 20, 2021

Avani Dave, Jai Hind College What is DKD? Diabetes is the major cause of chronic kidney disease (CKD) in the United States and across the world. Globally, an estimated 422 million individuals have diabetes, with up to 40% of them developing CKD over their lifespan. Diabetic kidney disease (DKD) is a pathological phenotype that does […]

kidney disease

Related Post

  • BiotechToday
  • World

DO COVID-19 PATIENTS BENEFIT FROM TOCILIZUMAB AT ALL?

bioxone October 25, 2020October 25, 2020

Arpan Banerjee, University of Calcutta Since the time Covid-19 has plagued the entire world, many studies have evolved emphasizing its heterogeneous clinical presentation, ranging from silent asymptomatic carriers to the severe ones bogged down with respiratory failure. The clinical trials about the finding of the wonder drug is still awaited. In the meantime, several drugs […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Apicomplexan parasites found sneak-peeking in human cells while gliding using molecular legs of host muscle protein

bioxone October 15, 2020October 15, 2020

Sristi Raj Rai, Amity University Kolkata Wanderers outside our body are in search of nutrients and host to persist and multiply to survive on the planet. Obligate endoparasite of Apicomplexa phylum invades human – intermediate/secondary hosts. These single-celled eukaryotes are of high medical and agricultural importance. Members such as Toxoplasma gondii and Plasmodium falciparum can […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Do lncRNA MCM3AP-AS1 develop lung cancer?

bioxone July 20, 2021July 19, 2021

Monika Raman, PSG College of Technology, Coimbatore Lung cancer, one of the most common and deadliest cancers, affected 2.2 million people and caused 1.79 million deaths worldwide in 2020. Most of the primary lung cancers are carcinomas. Small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC) are their two main types.  About 15% of lung […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy